Historical overview of nanotechnology and nanotoxicology

Methods in Molecular Biology

Volumn 926, Issue , 2012, Pages 1-12

  Santamaria, Annette ^a  

^a EXPONENT INC   (United States)

Author keywords

Consumer products; History; Nanomaterials; Nanotechnology; Nanotoxicology

Indexed keywords

NANOMATERIAL;

CHEMICAL INDUSTRY; NANOTECHNOLOGY; NANOTOXICOLOGY; PRIORITY JOURNAL; REVIEW; SAFETY;

EID: 84934443104     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-62703-2-1_1     Document Type: Review

References (65)

1. Zsigmondy R (1914) Colloids and the ultramicroscope. Wiley, New York
2. Feynman RP (1960) Theres plenty of room at the bottom. Eng Sci 23(5):22-36
3. Fanfair D, Desai S, Kelty C (2007) The early history of nanotechnology. Produced by the Connexions Project, Module m14504, Rice University. http://cnx.org/content/m14504/latest/. Accessed 16 July, 2012
4. Taniguchi N (1974) On the basic concept of nano-technology. In: Proceedings of the international conference of production engineering. Japan Society of Precision Engineering, Tokyo
5. Drexler KE (1981) Molecular engineering: an approach to the development of general capabilities for molecular manipulation. Proc Natl Acad Sci USA 78(9):5275-5278
6. Drexler KE (1986) Engines of creation: the coming era of nanotechnology. Random House, New York
7. Kroto H et al (1985) C60: buckminsterfullerene. Nature 318:162-163
8. Iijima S (1991) Helical microtubules of graphitic carbon. Nature 354:56-58
9. Colvin VL (2003) The potential environmental impact of engineered nanomaterials. Nat Biotechnol 21(10):1166-1170
10. National Center for Environmental Research (NCER), US Environmental Protection Agency (2003) Impacts of manufactured nanomaterials on human health and the environment. http://epa.gov/ncer/rfa/current/2003-nano.html . Accessed 16 July, 2012
11. UK Royal Society and Royal Academy of Engineering (2004) Nanoscience and nanotechnologies: opportunities and uncertainties. http://www.nanotec.org.uk/ finalReport.htm . Accessed 16 July, 2012
12. Hett A (2004) Nanotechnology. Small matter, many unknowns. SwissRe, Zurich
13. Oberdorster G et al (2005) Principles for characterizing the potential human health effects from exposure to nanomaterials: elements of a screening strategy. Part Fibre Toxicol 2:8
14. Wilson FJ Jr et al (1985) Quantitative deposition of ultra fine stable particles in the human respiratory tract. J Appl Physiol 58(1): 223-229
15. Ferin J et al (1990) Increased pulmonary toxicity of ultra fine particles. 1. Particle clearance, translocation, morphology. J Aerosol Sci 21: 381-384
16. Oberdorster G et al (1990) Increased pulmonary toxicity of ultra fine particles. 2. Lung lavage. J Aerosol Sci 21:384-387
17. Oberdorster G et al (1992) Role of the alveolar macrophage in lung injury: studies with ultra fine particles. Environ Health Perspect 97: 193-199
18. Churg A, Brauer M (2000) Ambient atmospheric particles in the airways of human lungs. Ultrastruct Pathol 24(6):353-361
19. Marty JJ, Oppenheim RC, Speiser P (1978) Nanoparticles -a new colloidal drug delivery system. Pharm Acta Helv 53(1):17-23
20. Couvreur P et al (1980) Tissue distribution of antitumor drugs associated with polyalkylcyanoacrylate nanoparticles. J Pharm Sci 69(2): 199-202
21. Kante B et al (1982) Toxicity of polyalkylcyanoacrylate nanoparticles I: free nanoparticles. J Pharm Sci 71(7):786-790
22. Kreuter J et al (1984) Toxicity and association of polycyanoacrylate nanoparticles with hepatocytes. J Microencapsul 1(3):253-257
23. Dussert AS, Gooris E, Hemmerle J (1997) Characterization of the mineral content of a physical sunscreen emulsion and its distribution onto human stratum corneum. Int J Cosmet Sci 19(3):119-129
24. P flucker F et al (2001) The human stratum corneum layer: an effective barrier against dermal uptake of different forms of topically applied micronised titanium dioxide. Skin Pharmacol Appl Skin Physiol 14(Suppl 1): 92-97
25. Bennat C, Muller-Goymann CC (2000) Skin penetration and stabilization offormulations containing micro fine titanium dioxide as physical UV filter. Int J Cosmet Sci 22(4): 271-283
26. Warheit DB et al (2004) Comparative pulmonary toxicity assessment of single-wall carbon nanotubes in rats. Toxicol Sci 77(1):117-125
27. Lam CW et al (2004) Pulmonary toxicity of single-wall carbon nanotubes in mice 7 and 90 days after intratracheal instillation. Toxicol Sci 77(1):126-134
28. Shvedova AA et al (2005) Unusual in flammatory and fibrogenic pulmonary responses to singlewalled carbon nanotubes in mice. Am J Physiol Lung Cell Mol Physiol 289(5):L698-L708
29. Oberdorster E (2004) Manufactured nanomaterials (fullerenes, C60) induce oxidative stress in the brain of juvenile largemouth bass. Environ Health Perspect 112(10):1058-1062
30. Donaldson K et al (2004) Nanotoxicology. Occup Environ Med 61(9):727-728
31. Warheit DB et al (2007) Pulmonary toxicity study in rats with three forms of ultra fine-TiO2 particles: differential responses related to surface properties. Toxicology 230(1):90-104
32. Shvedova AA et al (2008) Inhalation vs. aspiration of single-walled carbon nanotubes in C57BL/6 mice: in flammation, fibrosis, oxidative stress, and mutagenesis. Am J Physiol Lung Cell Mol Physiol 295(4):L552-L565
33. Sayes CM, Reed KL, Warheit DB (2007) Assessing toxicity offine and nanoparticles: comparing in vitro measurements to in vivo pulmonary toxicity pro files. Toxicol Sci 97(1): 163-180
34. Gopee NV et al (2007) Migration of intradermally injected quantum dots to sentinel organs in mice. Toxicol Sci 98(1):249-257
35. Park S et al (2007) Cellular toxicity of various inhalable metal nanoparticles on human alveolar epithelial cells. Inhal Toxicol 19(Suppl 1): 59-65
36. Baker GL et al (2008) Inhalation toxicity and lung toxicokinetics of C60 fullerene nanoparticles and microparticles. Toxicol Sci 101(1): 122-131
37. Ji JH et al (2007) Twenty-eight-day inhalation toxicity study of silver nanoparticles in Sprague-Dawley rats. Inhal Toxicol 19(10):857-871
38. Ryman-Rasmussen JP, Riviere JE, Monteiro-Riviere NA (2007) Variables in fluencing interactions of untargeted quantum dot nanoparticles with skin cells and identi fication of biochemical modulators. Nano Lett 7(5):1344-1348
39. Poland CA et al (2008) Carbon nanotubes introduced into the abdominal cavity of mice show asbestos-like pathogenicity in a pilot study. Nat Nanotechnol 3(7):423-428
40. Zhang LW, Monteiro-Riviere NA (2008) Assessment of quantum dot penetration into intact, tape-stripped, abraded and flexed rat skin. Skin Pharmacol Physiol 21(3):166-180
41. Muller J et al (2009) Absence of carcinogenic response to multiwall carbon nanotubes in a 2-year bioassay in the peritoneal cavity of the rat. Toxicol Sci 110(2):442-448
42. Robbens J et al (2010) Eco-, geno-and human toxicology of bio-active nanoparticles for biomedical applications. Toxicology 269(2-3):170-181
43. Porter DW et al (2010) Mouse pulmonary dose-and time course-responses induced by exposure to multi-walled carbon nanotubes. Toxicology 269(2-3):136-147
44. Riviere JE (2009) Pharmacokinetics of nanomaterials: an overview of carbon nanotubes, fullerenes and quantum dots. Wiley Interdiscip Rev Nanomed Nanobiotechnol 1(1):26-34
45. Yang RS et al (2010) Pharmacokinetics and physiologically-based pharmacokinetic modeling of nanoparticles. J Nanosci Nanotechnol 10(12):8482-8490
46. Kuzma J,VerHage P (2006) Nanotechnology in agriculture and food production. The project on emerging nanotechnologies. http://www. nanotechproject.org/publications/archive/nanotechnology-in-agriculture-food . Accessed 16 July, 2012
47. Williams D (2007) Carbon nanotubes in medical technology . Med Device Technol 18(2):8, 10
48. Christenson EM et al (2007) Nanobiomaterial applications in orthopedics. J Orthop Res 25(1):11-22
49. Yang X (2007) Nano-and microparticle-based imaging of cardiovascular interventions: overview. Radiology 243(2):340-347
50. Wang J et al (2008) Potential neurological lesion after nasal instillation of TiO(2) nanoparticles in the anatase and rutile crystal phases. Toxicol Lett 183(1-3):72-80
51. Bai S et al (2006) Recent progress in dendrimer-based nanocarriers. Crit Rev Ther Drug Carrier Syst 23(6):437-495
52. Lockman PR et al (2004) Nanoparticle surface charges alter blood-brain barrier integrity and permeability. J Drug Target 12(9-10):635-641
53. International Council on Nanotechnology (2010) Environment, Health, and Safety Database. http://cohesion.rice.edu/centersandinst/icon/report.cfm . Accessed 16 July, 2012
54. Environmental Defense and DuPont (ED/DuPont) (2007) Nano Risk Framework. A partnership of Environmental Defense Fund and DuPont. http://www. anoriskframework. com/. Accessed 16 July, 2012
55. Office GA (2010) Nanomaterials are widely used in commerce, but EPA faces challenges in regulating risk. In: Report to the Chairman, Committee on Environment and Public Works, US Senate
56. Thomas T et al (2009) Moving toward exposure and risk evaluation of nanomaterials: challenges and future directions. Wiley Interdiscip Rev Nanomed Nanobiotechnol 1(4):426-433
57. Chaudhry Q et al (2008) Applications and implications of nanotechnologies for the food sector. Food Addit Contam 25:241-258
58. Sandhiya S, Dkhar SA, Surendiran A (2009) Emerging trends of nanomedicine -an overview. Fundam Clin Pharmacol 23(3):263-269
59. Lee J, Mahendra S, Alvarez PJ (2010) Nanomaterials in the construction industry: a review of their applications and environmental health and safety considerations. ACS Nano 4(7):3580-3590
60. Hullmann A (2006) Who is winning the global nanorace? Nat Nanotechnol 1:81-83
61. Berger M (2007) Debunking the trillion dollar nanotechnology market size hype. NanoWerk. http://www.nanowerk.com/spotlight/spotid=1792.php . Accessed 16 July, 2012
62. U.S. Environmental Protection Agency (2009) Nanoscale Materials Stewardship Program, Interim Report. http://www.epa.gov/opptintr/nano/nmsp- interim-report-final.pdf. Accessed 16 July, 2012
63. UK Voluntary Reporting Scheme for engineered nanoscale materials (2008) Department for Environment, Food and Rural Affairs, London
64. European Parliament and of the Council on cosmotic products (2009) In: EC Regulation No. 1223/2009, C.o.t.E. Union (Editor)
65. European Parliament and of the Council of Food Additives (2008) In: EC Regulation No. 1333/2008, C.o.t.E. Union (Editor)